Search

everythinglearnresearchcommunity

for

Search:↓

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Tofacitinib is effective and safe for treating alopecia areata.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

The formulated gel is a promising treatment for alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.